PrimeVigilance, an Ergomed Group company, was founded in 2008 by Dr. Miroslav Reljanovic and co-founder Dr. Elliot Brown. The company specializes in providing top quality, cost-effective, and innovative clinical safety and PV services for pharmaceutical, biotechnology, and medical device companies. The leadership team, with a network of subject matter experts across the world, includes former senior regulators and industry consultants, contributing to the company's unrivaled reputation in the sector. PrimeVigilance's approach integrates medical and scientific knowledge with regulatory science to identify adverse effects or changes in their patterns, optimizing the safe and effective use of medicines and medical devices. The company's adaptable business models and integrative project management, combined with flexibility as a partner, consistently meet clients' business requirements and safeguard their assets. With a global team of 1000 professionals across 3 continents, PrimeVigilance is uniquely positioned in the clinical safety and pharmacovigilance space. Specializing in assisting both emerging and established pharma and biotech companies in compliance with regulations, the company offers a range of services from developing PV systems to full management of safety operations. Their commitment to patient safety aligns them closely with their clients. In summary, PrimeVigilance, with its strong industry reputation, global presence, and commitment to excellence in clinical safety and pharmacovigilance, presents a compelling opportunity for investment.
There is no investment information
No recent news or press coverage available for PrimeVigilance .